Business

Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest

Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and ChinaWilmington, Del., April 01, 2025 (GLOBE NEWSWIRE) -- Ashland has completed a 10-million-dollar expansion of its pharmaceutical manufacturing plant in Cabreúva, Brazil and will celebrate the occasion with a ribbon-cutting ceremony on April 4, 2025. The investment significantly expands Ashland’s pharmaceutical footprint in the region and capa

articleAshland Inc.April 1, 20254/company/ashland-global-holdings-inc/news/ashland-expands-pharmaceutical-plant-aquarius-105900422
Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest

About this update from Ashland Inc.

[{"type":"image","alt":"Ashland, Inc.","displaySize":"","headline":null,"caption":"Ashland, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":298,"height":107,"url":"https://media.zenfs.com/en/globenewswire.com/a06e04229ef00a7510c23ad9e6dccca9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ZUj030H5vAYxOzHbWF45cQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/a06e04229ef00a7510c23ad9e6dccca9","width":298,"height":107}},"lazy":false},{"type":"text","content":"Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and China","length":158,"tagName":"p"},{"type":"text","content":"Wilmington, Del., April 01, 2025 (GLOBE NEWSWIRE) -- Ashland has completed a 10-million-dollar expansion of its pharmaceutical manufacturing plant in Cabreúva, Brazil and will celebrate the occasion with a ribbon-cutting ceremony on April 4, 2025.","length":247,"tagName":"p"},{"type":"text","content":"The investment significantly expands Ashland’s pharmaceutical footprint in the region and capabilities to meet increasing market demand for coated tablets in Latin America and Brazil. Between 2019 and 2023 the consumption of coated tablets in Latin America had an average growth of 4.3 percent per year, while Brazil has reached growth of 5.7 percent per year+.","length":361,"tagName":"p"},{"type":"text","content":"The investment also includes the modernization of equipment for microbial protection in personal care applications at the Research and Development (R&D) laboratory of the company's Technical Center in São Paulo and follows the company’s previous investments to expand their bioresorbable polymers facility in Mullingar, Ireland and biofunctionals R&D lab in Shanghai, China. ","length":387,"tagName":"p"},{"type":"text","content":"“Our focused actions continue to demonstrate Ashland’s strategies to globalize, innovate and invest as a means of driving superior differentiation for customers and increase shareholder value,” said Guillermo Novo, chair and chief executive officer, Ashland. “The investments we have made in Cabreúva and São Paulo are supporting the globalization of our expertise in tablet coatings and microbial protection. They ensure even more innovation, collaboration and technical sup...

More updates from Ashland Inc.

Latin AmericaBrazilAshlandpharmaceutical manufacturingpersonal carecustomers